Tasly Pharmaceutical Group Co Ltd
医疗健康 · 专科与仿制药
Tasly Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers prescription drugs covering various therapeutic areas, including cardiovascular-cerebrovascular, tumor immunity, digestion and metabolism, and neuroscience; over-the-counter drugs; modern TCM; biological drugs; and chemical drugs. It also engages in medical instruments, agriculture, and chain drugstore activities. The company was formerly known as Tianjin Tasly Pharmaceutical Co., Ltd. and changed its name to Tasly Pharmaceutical Group Co., Ltd in May 2012. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is headquartered in Tianjin, China.
MARKET 市值 21.03B CNY PE 18.1x
Fwd 17.2x 52W ¥12.9 – ¥17.69
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 1.11 营收 YoY -13.5%
▼ ROE 8.7% 营业利润率 12.8% 净利润率 13.9%
ANALYST 股息率 2.21%